Paper7977482
Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.
Niwa T and 2 others. Am J Nephrol, 1994. Cited by 156 papers, by iCite.
Cite this record
ConductScience Library. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Papers, record 7977482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7977482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerulosclerosis, Focal Segmental | Major topic |
| Indican | Major topic |
| Indoles | Major topic |
| Kidney Glomerulus | Major topic |
| Uremia | Major topic |
| Animals | |
| Male | |
| Nephrectomy | |
| Rats | |
| Rats, Sprague-Dawley | |
| Tryptophan |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02929225 | Effectiveness of Probiotics to Treat End Stage Renal Disease | Background |
Source ClinicalTrials.gov
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41007509 | Effect of Spherical Adsorptive Carbon Among Chronic Kidney Disease Patients: A Nationwide Cohort Study. | Int J Environ Res Public Health | 2025 | https://conductscience.org/library/papers/41007509 | PubMed |
| 40135063 | Metabolomic profiling of adenine-induced CKD: pathway interconnections and kidney injury. | Toxicol Res (Camb) | 2025 | https://conductscience.org/library/papers/40135063 | PubMed |
| 40004925 | Benefits and Pitfalls of Uraemic Toxin Measurement in Peritoneal Dialysis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004925 | PubMed |
| 39924079 | Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1. | Cancer Lett | 2025 | https://conductscience.org/library/papers/39924079 | PubMed |
| 39478572 | Establishment of the auxin inducible degron system for Babesia duncani: a conditional knockdown tool to study precise protein regulation in Babesia spp. | Parasit Vectors | 2024 | https://conductscience.org/library/papers/39478572 | PubMed |
| 38787079 | A Historical Perspective on Uremia and Uremic Toxins. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38787079 | PubMed |
| 38612557 | Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612557 | PubMed |
| 38107705 | Protective effect of activated charcoal against progression of chronic kidney disease: A randomized clinical study. | J Med Life | 2023 | https://conductscience.org/library/papers/38107705 | PubMed |
| 38003343 | The AKI-to-CKD Transition: The Role of Uremic Toxins. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003343 | PubMed |
| 37686004 | Animal Models for Studying Protein-Bound Uremic Toxin Removal-A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686004 | PubMed |
| 37468049 | Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study. | J Ren Nutr | 2024 | https://conductscience.org/library/papers/37468049 | PubMed |
| 37175085 | Phosphoproteomic Approaches for Identifying Phosphatase and Kinase Substrates. | Molecules | 2023 | https://conductscience.org/library/papers/37175085 | PubMed |
| 35558102 | Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35558102 | PubMed |
| 35448883 | The Evolving View of Uremic Toxicity. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35448883 | PubMed |
| 35324718 | What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35324718 | PubMed |
| 34697401 | Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature. | Sci Rep | 2021 | https://conductscience.org/library/papers/34697401 | PubMed |
| 34055893 | Gaining Insights Into Metabolic Networks Using Chemometrics and Bioinformatics: Chronic Kidney Disease as a Clinical Model. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34055893 | PubMed |
| 33381933 | Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial. | Yonsei Med J | 2021 | https://conductscience.org/library/papers/33381933 | PubMed |
| 33311993 | Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease. | Int J Nephrol Renovasc Dis | 2020 | https://conductscience.org/library/papers/33311993 | PubMed |
| 33187079 | Encapsulation of Activated Carbon into a Hollow-Type Spherical Bacterial Cellulose Gel and Its Indole-Adsorption Ability Aimed at Kidney Failure Treatment. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/33187079 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7977482
GET https://conductscience.org/api/papers/v1/7977482/cited_by?page=2